Insulin lispro Sanofi

Medicinal product

(Invented) name

Insulin lispro Sanofi

Active substance (s)

Insulinas lispro

Strength

100 V/ml

Pharmaceutical form

injekcinis tirpalas užtaise

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10AB04, Insulin lispro

Marketing authorisation holder

Sanofi Winthrop Industrie, Prancūzija

Date of authorisation

2017-07-19

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in cartridge	1 ml
Insulinas lispro	100 V

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68880	83477	1083477	užtaisas	3 ml N5		Receptinis	EU/1/17/1203/001	Netiekiama	-	-	No	-	-
68881	83478	1083478	užtaisas	3 ml N10		Receptinis	EU/1/17/1203/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-07-19	Registruotas